Simmons Bank Astrazeneca PLC Transaction History

Simmons Bank

$1.48 Billion
Q3 2025

A detailed history of Simmons Bank transactions in Astrazeneca PLC stock. As of the latest transaction made, Simmons Bank holds 4,079 shares of AZN stock, worth $364,662. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,079

Previous 7,675 46.85%

Holding current value

$364,662

Previous $536,000 41.79%

% of portfolio

0.02%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	SELL	$68.72 - $82.11 $247,117 - $295,267	-3,596 Reduced 46.85%	4,079 $312,000
Q2 2025 Aug 05, 2025	SELL	$64.87 - $75.0 $81,541 - $94,275	-1,257 Reduced 14.07%	7,675 $536,000
Q1 2025 Apr 29, 2025	SELL	$65.37 - $77.96 $2.01 Million - $2.4 Million	-30,821 Reduced 77.53%	8,932 $656,000
Q4 2024 Feb 04, 2025	BUY	$63.2 - $79.58 $42,912 - $54,034	679 Added 1.74%	39,753 $2.6 Million
Q3 2024 Nov 05, 2024	BUY	$76.67 - $87.62 $204,172 - $233,332	2,663 Added 7.31%	39,074 $3.04 Million

Q2 2024 Jul 26, 2024	BUY	$66.81 - $80.83 $177,848 - $215,169	2,662 Added 7.89%	36,411 $2.84 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $647,833 - $738,485	10,615 Added 45.88%	33,749 $2.29 Million
Q4 2023 Feb 06, 2024	BUY	$61.89 - $69.28 $1.16 Million - $1.3 Million	18,765 Added 429.5%	23,134 $1.56 Million
Q3 2023 Oct 26, 2023	BUY	$64.85 - $71.7 $3,372 - $3,728	52 Added 1.2%	4,369 $295,000
Q2 2023 Aug 03, 2023	BUY	$69.91 - $75.81 $17,966 - $19,483	257 Added 6.33%	4,317 $308,000
Q4 2022 Feb 08, 2023	SELL	$54.21 - $70.44 $71,286 - $92,628	-1,315 Reduced 24.47%	4,060 $275,000
Q3 2022 Oct 27, 2022	SELL	$53.02 - $135.75 $17,655 - $45,204	-333 Reduced 5.83%	5,375 $295,000
Q1 2022 Apr 21, 2022	SELL	$55.72 - $67.12 $11,199 - $13,491	-201 Reduced 3.4%	5,708 $379,000
Q3 2021 Oct 26, 2021	BUY	$55.56 - $60.79 $328,304 - $359,208	5,909 New	5,909 $355,000
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $201,534 - $273,742	-5,333 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$42.46 - $50.46 $4,246 - $5,046	-100 Reduced 1.84%	5,333 $266,000
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $250,749 - $284,187	-6,250 Reduced 53.5%	5,433 $242,000
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $52,937 - $59,185	-1,420 Reduced 10.84%	11,683 $482,000
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $1,526 - $1,849	-43 Reduced 0.33%	13,103 $530,000
Q4 2018 Jan 24, 2019	SELL	$36.86 - $41.49 $42,389 - $47,713	-1,150 Reduced 8.04%	13,146 $500,000
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $164,101 - $187,518	4,721 Added 49.31%	14,296 $566,000
Q2 2018 Aug 13, 2018	BUY	$34.55 - $37.05 $13,992 - $15,005	405 Added 4.42%	9,575 $335,000
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $302,334 - $335,897	9,170 New	9,170 $320,000

Others Institutions Holding AZN

# of Institutions

1,536

Shares Held

502M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simmons Bank, based on Form 13F filings with the SEC.

News

Stay updated on Simmons Bank with notifications on news.

Account